Keshavarz, Mohsen, Karbalaie Niya, Mohammad Hadi, Tameshkel, Fahimeh Safarnezhad et al. · Journal of pharmacy & bioallied sciences · 2018 · DOI
Researchers in Iran tested 291 patients suspected of having HTLV-1 (a virus that affects the immune system) to see if they also had XMRV, another virus that has been studied in connection with chronic fatigue syndrome. They found that 32% of patients had HTLV-1, but only 1 out of 93 HTLV-1-positive patients also had XMRV. This suggests that having both viruses together is very rare in this population.
Since XMRV has been proposed as a potential pathogen in ME/CFS and might interact with other infections, understanding its prevalence and coinfection patterns is important for clarifying disease etiology. This study provides epidemiological data on XMRV detection rates in a specific population and infection context, contributing to the global understanding of XMRV distribution and its relationship to other viral infections.
This study does not prove that XMRV and HTLV-1 cannot coexist or that XMRV plays no role in ME/CFS pathogenesis. The very low detection rate in this Iranian cohort does not rule out XMRV's presence or importance in other populations, geographic regions, or patient subgroups. Cross-sectional design cannot establish causality or determine whether rare coinfections have clinical significance.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →